The present invention provides a pharmaceutical composition including a therapeutically efficient amount of a compound represented by formula (1), at least an anticancer agent, and a pharmaceutically acceptable carrier. The present invention further provides a use of the compound represented by formula (1) for the manufacture of a medicament for treating hepatocellular carcinoma.